Traws Pharma, Inc. - Director's Dealing 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: Michael & Jane Hoffman 2013 Descendants (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	C	83857	—	Acquired	728517	Direct
2013-07-30	Common Stock	C	105363	—	Acquired	833880	Direct
2013-07-30	Common Stock	C	266712	—	Acquired	1100592	Direct
2013-07-30	Common Stock	C	476087	—	Acquired	1576679	Direct
2013-07-30	Common Stock	C	85744	—	Acquired	1662423	Direct
2013-07-30	Common Stock	C	172411	—	Acquired	1834834	Direct
2013-07-30	Common Stock	C	226024	—	Acquired	2060858	Direct
2013-07-30	Common Stock	C	1226942	—	Acquired	3287800	Direct
2013-07-30	Common Stock	P	1000000	$15.00	Acquired	4287800	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Underlying	Ownership
2013-07-30	Series B Convertible Preferred Stock	$	C	99350	Disposed	Common Stock (83857)	Direct
2013-07-30	Series C Convertible Preferred Stock	$	C	140449	Disposed	Common Stock (105363)	Direct
2013-07-30	Series D Convertible Preferred Stock	$	C	355528	Disposed	Common Stock (266712)	Direct
2013-07-30	Series E Covertible Preferred Stock	$	C	634625	Disposed	Common Stock (476087)	Direct
2013-07-30	Series F Convertible Preferred Stock	$	C	111227	Disposed	Common Stock (85744)	Direct
2013-07-30	Series G Convertible Preferred Stock	$	C	229825	Disposed	Common Stock (172411)	Direct
2013-07-30	Series H COnvertible Preferred Stock	$	C	301290	Disposed	Common Stock (226024)	Direct
2013-07-30	Series I Convertible Preferred Stock	$	C	1635514	Disposed	Common Stock (1226942)	Direct

F1: The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.

F2: The Series C Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F3: The Series D Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F4: The Series E Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F5: The Series F Convertible Preferred Stock converted into Common Stock on a 0.77-for-1 basis and had no expiration date.

F6: The Series G Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F7: The Series H Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F8: The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.